Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01492335 · ClinicalTrials.gov registry record · NA

Cognitive Assessment of Elderly Primary Care Patients

A NA study of Mild Cognitive Impairment, sponsored by University of Pittsburgh.

Completed
Registry status
NA
Development phase
524
Enrollment target
1
Study location

NCT01492335: Completed NA study of Mild Cognitive Impairment, sponsored by University of Pittsburgh.

NCT01492335 is a NA study of Mild Cognitive Impairment that has completed, run by University of Pittsburgh. The registered enrollment target is 524 participants, below the 1,268-participant average among 205 other Mild Cognitive Impairment trials with a reported enrollment target (59% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01492335, a NA study of Mild Cognitive Impairment, has completed, sponsored by University of Pittsburgh.

COMPLETED
Registry status
NA
Development phase
524 participants
Enrollment target
1
Study location

Study Summary

Most primary care physicians do not screen older patients for cognitive impairment. Identification of cognitive impairment may result in earlier referral for diagnostic work-up and earlier treatment and better patient outcomes. The purpose of this study is to determine whether physicians who receive the results of a cognitive screen use this information in treatment plans and whether this results in better cognitive outcomes for the older patients.

Primary Outcome

Diagnosis is based on performance on a standard neuropsychological test battery that assesses mutliple cognitive domains known to be sensitive to early dementia.

Conditions Studied

Interventions

  • BEHAVIORAL Treatment As Usual
  • BEHAVIORAL Cognitive Report

Study Locations (1)

Pennsylvania

  • University of Pittsburgh - Pittsburgh

Trial Details

FieldValue
Enrollment Target 524 participants
Start Date 2006-01
Est. Completion 2012-08
Phase NA
University of Pittsburgh

1,238 total trials

What the finished NCT01492335 record still lists

NCT01492335 is an interventional study that assigns participants to a tested intervention. The registered 524 participants enrollment target is mid-sized for trials with a published cap, below the 1,268-participant average among 205 other Mild Cognitive Impairment trials with a reported enrollment target (59% lower).

The record links to 1 condition, with Mild Cognitive Impairment appearing as the primary indexed condition, and to 2 interventions - of which Treatment As Usual is the first listed.

NCT01492335 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT01492335 about?

NCT01492335 is a clinical study titled "Cognitive Assessment of Elderly Primary Care Patients". Most primary care physicians do not screen older patients for cognitive impairment. Identification of cognitive impairment may result in earlier referral for diagnostic work-up and earlier treatment and better patient outcomes. The purpose of this study is to determine whether physicians who receive...

What is the current status of trial NCT01492335?

This trial is currently completed. It is a NA study. The enrollment target is 524 participants. The study started on 2006-01. Estimated completion is 2012-08.

What conditions does trial NCT01492335 study?

This clinical trial studies the following conditions: Mild Cognitive Impairment.

What interventions are being tested in trial NCT01492335?

The interventions under investigation include: Treatment As Usual (BEHAVIORAL), Cognitive Report (BEHAVIORAL).

Who is sponsoring clinical trial NCT01492335?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01492335 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Mild Cognitive Impairment

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01492335's enrollment target sits among peer trials

524 20th of 205 higher than 186 of 205 other Mild Cognitive Impairment trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Mild Cognitive Impairment trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04580134 · 524 participants · Phase 4

    CLOZAPINE Response in Biotype-1

  • NCT07158814 · 524 participants · Phase 4

    Safety of RSV Preventive Monoclonal Antibody

  • NCT04769492 · 525 participants · NA

    #ChopViolence/#ChopHIV

  • NCT05260047 · 525 participants · NA

    Culturally Responsive Community Driven Substance Use Recovery for Black and Latinx Population

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01492335, the US trial registry maintained by the National Library of Medicine. NCT01492335 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.